Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Browse by Journal Title

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type
Jump to: 2016 | 2012 | 2007 | 2003 | 2002 | 2001 | 2000 | 1997 | 1995

2016

CCL4 as an adjuvant for DNA vaccination in a Her2/neu mouse tumor model.
Nguyen-Hoai, T. and Pham-Duc, M. and Gries, M. and Dörken, B. and Pezzutto, A. and Westermann, J.
Cancer Gene Therapy 23 (6): 162-167. June 2016

2012

CCL19 as an adjuvant for intradermal gene gun immunization in a Her2/neu mouse tumor model: improved vaccine efficacy and a role for B cells as APC.
Nguyen-Hoai, T. and Hohn, O. and Vu, M.D. and Baldenhofer, G. and Sayed Ahmed, M.S. and Doerken, B. and Norley, S. and Lipp, M. and Pezzutto, A. and Westermann, J.
Cancer Gene Therapy 19 (12): 880-887. December 2012

CCL21 (SLC) improves tumor protection by a DNA vaccine in a Her2/neu mouse tumor model.
Nguyen-Hoai, T. and Baldenhofer, G. and Sayed Ahmed, M.S. and Pham-Duc, M. and Vu, M.D. and Lipp, M. and Doerken, B. and Pezzutto, A. and Westermann, J.
Cancer Gene Therapy 19 (1): 69-76. January 2012

2007

CCL19 (ELC) as an adjuvant for DNA vaccination: induction of a TH1-type T-cell response and enhancement of antitumor immunity.
Westermann, J. and Nguyen-Hoai, T. and Baldenhofer, G. and Hoepken, U.E. and Lipp, M. and Doerken, B. and Pezzutto, A.
Cancer Gene Therapy 14 (6): 523-532. June 2007

2003

Lipoplexes with alkylphospholipid as new helper lipid for efficient in vitro and in vivo gene transfer in tumor therapy.
Zeisig, R. and Ress, A. and Fichtner, I. and Walther, W.
Cancer Gene Therapy 10 (4): 302-311. April 2003

2002

Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2.
Kowalski, P. and Stein, U. and Scheffer, G.L. and Lage, H.
Cancer Gene Therapy 9 (7): 579-586. July 2002

Adenovirus-mediated gene transfer of P161NK4/CDKN2 into bax-negative colon cancer cells induces apoptosis and tumor regression in vivo.
Tamm, I. and Schumacher, A. and Karawajew, L. and Ruppert, V. and Arnold, W. and Nuessler, A.K. and Neuhaus, P. and Doerken, B. and Wolff, G.
Cancer Gene Therapy 9 : 641-650. 1 January 2002

2001

Effects of adenoviral wild-type p53 gene transfer in p53-mutated lymphoma cells.
Buttgereit, P. and Schakowski, F. and Maerten, A. and Brand, K. and Renoth, S. and Ziske, C. and Schoettker, B. and Ebert, O. and Schroers, R. and Schmidt-Wolf, I.G.H.
Cancer Gene Therapy 8 : 430-439. 1 January 2001

2000

Efficient gene transfer into lymphoma cells using adenoviral vectors combined with lipofection.
Buttgereit, P. and Weineck, S. and Ropke, G. and Marten, A. and Brand, K. and Heinicke, T. and Caselmann, W.H. and Huhn, D. and Schmidt-Wolf, I.
Cancer Gene Therapy 7 : 1145-1155. 1 August 2000

mdr1 promoter-driven tumor necrosis factor-alpha expression for a chemotherapy-controllable combined in vivo gene therapy and chemotherapy of tumors.
Walther, W. and Stein, U. and Fichtner, I. and Alexander, M. and Shoemaker, R.H. and Schlag, P.M.
Cancer Gene Therapy 7 (6): 893-900. 1 June 2000

Combined chemotherapy of murine mammary tumors by local activation of the prodrugs ifosfamide and 5-fluorocytosine.
Kammertoens, T. and Gelbmann, W. and Karle, P. and Alton, K. and Saller, R. and Salmons, B. and Guenzburg, W.H. and Uckert, W.
Cancer Gene Therapy 7 (4): 629-636. 1 April 2000

1997

Liver associated toxicity of the hsv tk/gcv approach and adenoviral vectors.
Brand, K. and Arnold, W. and Bartels, T. and Lieber, A. and Kay, M.A. and Strauss, M. and Doerken, B.
Cancer Gene Therapy 4 (1): 9-16. 1 January 1997

1995

Vectors in cancer therapy: how will they deliver.
Blaese, M. and Blankenstein, T. and Brenner, M. and Cohen-Haguenauer, O. and Gansbacher, B. and Russell, S. and Sorrentino, B. and Velu, T.
Cancer Gene Therapy 2 (4): 291-297. 1 January 1995

This list was generated on Thu Oct 18 02:28:10 2018 CEST.
Open Access
MDC Library